Stay updated on Tezepelumab in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tezepelumab in Atopic Dermatitis Clinical Trial page.

Latest updates to the Tezepelumab in Atopic Dermatitis Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated to reflect a new version of a clinical study on tezepelumab for atopic dermatitis, including changes in the study revision number and the removal of detailed inclusion and exclusion criteria. The collaborators for the study have been confirmed as AstraZeneca.SummaryDifference33%
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check58 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
- Check74 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.7%
- Check81 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.0%
Stay in the know with updates to Tezepelumab in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Atopic Dermatitis Clinical Trial page.